The mechanism by which the opportunistic pathogen Candida albicans initiates infection is poorly understood. Several lines of circumstantial evidence have suggested that proteinase production may be involved in pathogenicity. It has been shown that most strains of C. albicans produce proteinase, while many less-virulent species (e.g., C. glabrata and C. krusei) do not (6, 8, 9) . In addition, several strains which produce high levels of proteinase in vitro have been shown to be more virulent in experimental mouse infections than strains which produce less proteinase. By staining infected tissue with antibody to proteinase, Ruchel (7) and MacDonald and Odds (3) have demonstrated that proteinase, or something that cross-reacts with it, is produced by the fungus in vivo.
The most suggestive evidence for the involvement of extracellular proteinases in the pathogenicity of C. albicans has come from recent reports by MacDonald and Odds (4) and by Kwon-Chung et al. (1) . In each report, proteinasedeficient strains were isolated from wild-type parental strains by mutagenesis. Although neither mutant was completely proteinase negative (both produced a lower level of proteinase in vitro than did the parent), both mutants were significantly less virulent than the parental strains. KwonChung et al. also documented that reversion of their proteinase-deficient mutant to partial proteinase production restored virulence. While the exact nature of the mutations in these strains is undefined, these results are consistent with a role for extracellular proteinases in the pathogenicity of C.
albicans.
In 1983, Manning et al. (5) discrete round masses of organisms that could be dislodged easily from the renal calices but no evidence of the miliary foci of infection throughout the kidney tissue characteristic of infection by the parent strain. MY1049 produced abundant mycelium both in vivo and in vitro and grew as rapidly as the parent when tested in rich media in vitro.
To determine whether a deficiency in extracellular proteinase was responsible for the noninvasive nature of the infection caused by MY1049, we compared the growth and extracellular acid proteinase production of our low-virulence mutant, MY1049, with those of its virulent parent, MY1044.
To induce proteinase production, cells were washed from 48-h-old glucose-yeast extract agar (Difco Laboratories, Detroit, Mich.) slants and inoculated into BSA + SER medium (yeast carbon base [Difco] , 0.2% bovine serum albumin [BSA] , serine [30 ,ug/ml]) at an initial cell concentration of 5 x 105 cells per ml. Cells were quantitated in a hemacytometer at 24-h intervals, and the proteinase activity of culture supernatants was also determined. After the pH of the supernatants was adjusted to pH 4.0, each was diluted with 0.1 M sodium acetate buffer, pH 4.0, and incubated with BSA (final concentration, 2 mg/ml in 0.05 M acetate buffer, pH 4.0) for 2 h at 35°C. The reaction was stopped by the addition of trichloroacetic acid (TCA) to a final concentration of 5%, and the samples were chilled for 30 min. The TCA-insoluble material was removed by centrifugation, and the acid-soluble proteolytic products were quantitated by the method of Lowry et al. (2) . One unit of proteinase activity was defined as that amount of proteinase which released 10 pg of acid-soluble peptides per ml in 2 h.
Cultures were incubated at both the permissive (28°C) and the nonpermissive (35°C) temperatures to determine whether the requirement for serine affected proteinase production. Experiments were performed three times; typical results are shown in Fig. 1 and total proteinase activity (B) were measured each day, and the specific activity (C) was calculated for each culture. stationary phase on day 2, whereas MY1049 reached stationary phase on day 4.
Significant levels of proteinase activity were detected in the parental culture by day 1 and did not significantly increase thereafter. In contrast, very little proteinase activity was detected in the mutant culture until day 4 (Fig. 1B) . However, when proteinase activity was corrected for cell number (units per 106 cells), it was noted that, for the first 48 h, the specific activity of MY1049 extracellular proteinase was the same as that of MY1044 extracellular proteinase. At later times, the MY1049 culture actually contained more proteinase per cell than did the MY1044 culture (Fig. 1C) .
At 28°C, the growth of MY1044 and MY1049 in yeast nitrogen base (Difco) supplemented with glucose (0.5%) and serine (30 ,uLg/ml) was compared to determine whether the growth of MY1049 was slower than that of the parent in a medium containing ammonium sulfate as the nitrogen source. In this medium, MY1049 was able to grow at the same rate as was the parent, and stationary phase was reached after 30 h (data not shown).
In comparison with growth at 28°C, similar results were obtained when MY1044 and MY1049 were grown in BSA + SER at 35°C. Strain MY1049 grew significantly more slowly than did MY1044. While the parental culture reached stationary phase by day 2, the mutant did not reach stationary phase until day 5 ( Fig. 2A) . The total extracellular proteinase activity of the MY1049 culture was also much lower than that of the MY1044 culture until day 4, when it reached the maximum level (Fig. 2B) . Once again, however, the specific activity of the MY1049 culture was the same as that of the MY1044 culture for the first 48 h and was significantly higher thereafter (Fig. 2C) .
It is important to note that the total extracellular proteinase activity of the MY1044 culture actually decreased during the last 3 days of growth. It is likely that this decline was due to pH inactivation of the enzyme. The pH of the MY1044 culture medium (35°C) increased to 5.8 by day 3 (Fig. 3) , while the pH of the MY1049 culture medium remained below 5.0. The pH of the MY1044 culture medium incubated at 28°C did not increase to pH 6.1 until day 4. The extracellular proteinases from both cultures were rapidly inactivated at pH 7.0 (data not shown).
Because enzymes are classified on the basis of their susceptibility to inhibitors, several known enzyme inhibitors were tested for their ability to inhibit the extracellular proteinases produced by MY1044 and MY1049 at both 28°C and 35°C to determine whether any differences could be detected. After 4 days of incubation, culture supernatants were collected, diluted (final concentration, 0.05 M sodium acetate buffer, pH 4.0), and incubated with each inhibitor at 25°C for 30 min prior to assay for proteinase activity. The inhibitors (Sigma Chemical Co., St. Louis, Mo.) were phenylmethylsulfonyl fluoride (PMSF), 1,2-epoxy-3-(p-nitro-phenoxy propane (EPNP), diazoacetyl-DL-norleucine methyl ester (DAN), pepstatin, and EDTA. Stock solutions of pepstatin, EPNP, and DAN were made with methanol. EDTA was dissolved in water, and PMSF was prepared in ethanol. Pepstatin was the only compound that inhibited proteinase activity. At the lowest concentration tested (10 ,uM) , pepstatin inhibited 95 to 100% of the proteinase activity of all four supernatants. No inhibition of activity was seen with PMSF (20 mM), EDTA (5 mM), EPNP (10 mM), or DAN (1 mM).
The results suggest that the mutant may be unable to utilize BSA as a nitrogen source as efficiently as the parent strain does, despite the fact that extracellular proteinases are secreted. In media supplemented with serine, with ammonium as a nitrogen source, MY1049 was able to grow as rapidly as MY1044. Because MY1049 grew more slowly than did MY1044 in the BSA medium, the total amount of proteinase that accumulated in the MY1049 culture was significantly lower than the amount that accumulated in the MY1044 culture. Kwon-Chung et al. (1) have suggested that a threshold level of proteinase may be required in vivo to facilitate the pathogenicity of C. albicans. Slow growth in vivo might also prevent the mutant from accumulating this threshold level of proteinase. Thus, although these experiments do not directly address the importance of proteinase production in the virulence of C. albicans, the results can be interpreted as being consistent with such a role. The decreased ability of strain MY1049 to grow in a protein-rich environment, despite its ability to produce extracellular proteinase, may enable the host to contain the mutant strain before the fungal cells can invade the tissue.
Studies have been initiated in our laboratory to assess the role of proteinase activity in vivo. Tsuobi et al. (10) have shown that pepstatin, an inhibitor of carboxyl proteinases, was fungistatic against a proteolytic strain of C. albicans. To determine whether pepstatin could protect against infection in vivo, preliminary experiments were performed by infecting mice with C. albicans (6 x 106 cells per mouse) and by treating them with pepstatin in four daily doses ranging from 10 to 500 FLg/kg. No changes were observed in either the survival of the infected mice or the gross pathology of the infection. It is impossible to tell from these early data whether the pepstatin actually inhibited proteinase activity at the site of infection.
We thank R. A. Fromtling and G. K. Abruzzo for providing us with the data from the in vivo experiments.
